These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7490729)

  • 1. Identification of a series of 3-(benzyloxy)-1-azabicyclo[2.2.2]octane human NK1 antagonists.
    Swain CJ; Seward EM; Cascieri MA; Fong TM; Herbert R; MacIntyre DE; Merchant KJ; Owen SN; Owens AP; Sabin V
    J Med Chem; 1995 Nov; 38(24):4793-805. PubMed ID: 7490729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of 8-azabicyclo[3.2.1]octane benzylamine NK1 antagonists.
    Thomson CG; Carlson E; Chicchi GG; Kulagowski JJ; Kurtz MM; Swain CJ; Tsao KL; Wheeldon A
    Bioorg Med Chem Lett; 2006 Feb; 16(4):811-4. PubMed ID: 16307878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Phenyl-8-azabicyclo[3.2.1]octane ethers: a novel series of neurokinin (NK1) antagonists.
    Huscroft IT; Carlson EJ; Chicchi GG; Kurtz MM; London C; Raubo P; Wheeldon A; Kulagowski JJ
    Bioorg Med Chem Lett; 2006 Apr; 16(7):2008-12. PubMed ID: 16413782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2,3-disubstituted 6-azabicyclo[3.2.1]octanes as novel dopamine transporter inhibitors.
    Quirante J; Vila X; Bonjoch J; Kozikowski AP; Johnson KM
    Bioorg Med Chem; 2004 Mar; 12(6):1383-91. PubMed ID: 15018911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and modeling studies of a potent conformationally rigid muscarinic agonist: 1-azabicyclo[2.2.1]heptanespirofuranone.
    Wu ES; Kover A; Semus SF
    J Med Chem; 1998 Oct; 41(22):4181-5. PubMed ID: 9784090
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and dopamine transporter affinity of 2-(methoxycarbonyl)-9-methyl-3-phenyl-9-azabicyclo[3.3.1]nonane derivatives.
    Chen Z; Izenwasser S; Katz JL; Zhu N; Klein CL; Trudell ML
    J Med Chem; 1996 Nov; 39(24):4744-9. PubMed ID: 8941387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to syn-7-substituted 2-azanorbornanes as potential nicotinic agonists; synthesis of syn- and anti-isoepibatidine.
    Malpass JR; Handa S; White R
    Org Lett; 2005 Jun; 7(13):2759-62. PubMed ID: 15957940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification, biological characterization and pharmacophoric analysis of a new potent and selective NK1 receptor antagonist clinical candidate.
    Di Fabio R; Alvaro G; Braggio S; Carletti R; Gerrard PA; Griffante C; Marchioro C; Pozzan A; Melotto S; Poffe A; Piccoli L; Ratti E; Tranquillini E; Trower M; Spada S; Corsi M
    Bioorg Med Chem; 2013 Nov; 21(21):6264-73. PubMed ID: 24075145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of ethyl 5-phenyl-6-oxa-1-azabicyclo[3.1.0]hexane-2-carboxylate derivatives and evaluation of their antimalarial activities.
    Ningsanont N; Black DS; Chanphen R; Thebtaranonth Y
    J Med Chem; 2003 Jun; 46(12):2397-403. PubMed ID: 12773043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of azabicyclo[2.2.n]alkane systems as analogues of 3-[1-methyl-2-(S)-pyrrolidinyl- methoxy]pyridine (A-84543).
    Carreras J; Avenoza A; Busto JH; Peregrina JM
    J Org Chem; 2007 Apr; 72(8):3112-5. PubMed ID: 17371077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonists.
    Morriello GJ; Devita RJ; Mills SG; Young JR; Lin P; Doss G; Chicchi GG; Demartino J; Kurtz MM; Tsao KL; Carlson E; Townson K; Wheeldon A; Boyce S; Collinson N; Rupniak N; Moore S
    Bioorg Med Chem; 2008 Mar; 16(5):2156-70. PubMed ID: 18248994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters.
    Kolhatkar R; Cook CD; Ghorai SK; Deschamps J; Beardsley PM; Reith ME; Dutta AK
    J Med Chem; 2004 Oct; 47(21):5101-13. PubMed ID: 15456254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meriolins (3-(pyrimidin-4-yl)-7-azaindoles): synthesis, kinase inhibitory activity, cellular effects, and structure of a CDK2/cyclin A/meriolin complex.
    Echalier A; Bettayeb K; Ferandin Y; Lozach O; Clément M; Valette A; Liger F; Marquet B; Morris JC; Endicott JA; Joseph B; Meijer L
    J Med Chem; 2008 Feb; 51(4):737-51. PubMed ID: 18232649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative configuration, absolute configuration and absolute structure of three isomeric 8-benzyl-2-[(4-bromophenyl)(hydroxy)methyl]-8-azabicyclo[3.2.1]octan-3-ones.
    Brzezinski K; Lazny R; Nodzewska A; Sidorowicz K
    Acta Crystallogr C; 2013 Mar; 69(Pt 3):303-6. PubMed ID: 23459361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of azabicyclo[3.2.1]octane derivatives as potent mixed vasopressin antagonists.
    Crombie AL; Antrilli TM; Campbell BA; Crandall DL; Failli AA; He Y; Kern JC; Moore WJ; Nogle LM; Trybulski EJ
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3742-5. PubMed ID: 20471258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereocontrolled synthesis of angularly substituted 1-azabicyclic rings by cationic 2-aza-cope rearrangements.
    Aron ZD; Overman LE
    Org Lett; 2005 Mar; 7(5):913-6. PubMed ID: 15727473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton and their pharmacologies.
    Watanabe Y; Kitazawa S; Fujii H; Nemoto T; Hirayama S; Nagase H
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2689-92. PubMed ID: 22445285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 7-substituted 2-azabicyclo[2.2.1]heptanes as key intermediates for the synthesis of novel epibatidine analogues; synthesis of syn-and anti-isoepiboxidine.
    Malpass JR; White R
    J Org Chem; 2004 Aug; 69(16):5328-34. PubMed ID: 15287778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 1-azabicyclo[3.3.0]octane derivatives and their effects as piracetam-like nootropics.
    Oka M; Matsumoto Y; Hirooka K; Suzuki T
    Chem Pharm Bull (Tokyo); 2000 Aug; 48(8):1121-4. PubMed ID: 10959574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptophan-derived NK1 antagonists: conformationally constrained heterocyclic bioisosteres of the ester linkage.
    Lewis RT; Macleod AM; Merchant KJ; Kelleher F; Sanderson I; Herbert RH; Cascieri MA; Sadowski S; Ball RG; Hoogsteen K
    J Med Chem; 1995 Mar; 38(6):923-33. PubMed ID: 7699709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.